233 related articles for article (PubMed ID: 10659019)
1. Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth.
McCutcheon IE; Friend KE; Gerdes TM; Zhang BM; Wildrick DM; Fuller GN
J Neurosurg; 2000 Feb; 92(2):306-14. PubMed ID: 10659019
[TBL] [Abstract][Full Text] [Related]
2. A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigation.
Ragel BT; Elam IL; Gillespie DL; Flynn JR; Kelly DA; Mabey D; Feng H; Couldwell WT; Jensen RL
J Neurosurg; 2008 Feb; 108(2):304-10. PubMed ID: 18240927
[TBL] [Abstract][Full Text] [Related]
3. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.
Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C
Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408
[TBL] [Abstract][Full Text] [Related]
4. An orthotopic skull base model of malignant meningioma.
Baia GS; Dinca EB; Ozawa T; Kimura ET; McDermott MW; James CD; VandenBerg SR; Lal A
Brain Pathol; 2008 Apr; 18(2):172-9. PubMed ID: 18093250
[TBL] [Abstract][Full Text] [Related]
5. Implantation of human meningiomas into the subrenal capsule of the nude mouse. A model for studies of tumor growth.
Medhkour A; Van Roey M; Sobel RA; Fingert HJ; Lee J; Martuza RL
J Neurosurg; 1989 Oct; 71(4):545-50. PubMed ID: 2477514
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the cell lines used in meningioma research.
Ragel BT; Couldwell WT; Gillespie DL; Wendland MM; Whang K; Jensen RL
Surg Neurol; 2008 Sep; 70(3):295-307; discussion 307. PubMed ID: 18261772
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee.
Lee WH
Neurosurgery; 1990 Sep; 27(3):389-95; discussion 396. PubMed ID: 2234331
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice.
McCutcheon IE; Flyvbjerg A; Hill H; Li J; Bennett WF; Scarlett JA; Friend KE
J Neurosurg; 2001 Mar; 94(3):487-92. PubMed ID: 11235955
[TBL] [Abstract][Full Text] [Related]
10. Matrigel augments xenograft transplantation of meningioma cells into athymic mice.
Jensen RL; Leppla D; Rokosz N; Wurster RD
Neurosurgery; 1998 Jan; 42(1):130-5; discussion 135-6. PubMed ID: 9442514
[TBL] [Abstract][Full Text] [Related]
11. Effect of systemic celecoxib on human meningioma after intracranial transplantation into nude mice.
Friedrich S; Schwabe K; Grote M; Krauss JK; Nakamura M
Acta Neurochir (Wien); 2013 Jan; 155(1):173-82. PubMed ID: 23143216
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.
Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT
Cancer; 2007 Feb; 109(3):588-97. PubMed ID: 17177201
[TBL] [Abstract][Full Text] [Related]
13. Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
Ragel BT; Gillespie DL; Kushnir V; Polevaya N; Kelly D; Jensen RL
Neurosurgery; 2006 Nov; 59(5):1109-20; discussion 1120-1. PubMed ID: 17143245
[TBL] [Abstract][Full Text] [Related]
14. mTORC1 inhibitors suppress meningioma growth in mouse models.
Pachow D; Andrae N; Kliese N; Angenstein F; Stork O; Wilisch-Neumann A; Kirches E; Mawrin C
Clin Cancer Res; 2013 Mar; 19(5):1180-9. PubMed ID: 23406776
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T
J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837
[TBL] [Abstract][Full Text] [Related]
16. Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line.
Kondraganti S; Gondi CS; Gujrati M; McCutcheon I; Dinh DH; Rao JS; Olivero WC
Int J Oncol; 2006 Jul; 29(1):25-32. PubMed ID: 16773181
[TBL] [Abstract][Full Text] [Related]
17. Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1.
Michelhaugh SK; Guastella AR; Varadarajan K; Klinger NV; Parajuli P; Ahmad A; Sethi S; Aboukameel A; Kiousis S; Zitron IM; Ebrahim SA; Polin LA; Sarkar FH; Bollig-Fischer A; Mittal S
J Transl Med; 2015 Jul; 13():227. PubMed ID: 26174772
[TBL] [Abstract][Full Text] [Related]
18. [Primary culture of human malignant meningioma cells and its intracranial orthotopic transplantation in nude mice].
Hu MX; Liu JL; Chen XB; Xu AQ; Shu SR; Wang CH; Liu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):340-345. PubMed ID: 29643042
[TBL] [Abstract][Full Text] [Related]
19. Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.
Gupta V; Su YS; Samuelson CG; Liebes LF; Chamberlain MC; Hofman FM; Schönthal AH; Chen TC
J Neurosurg; 2007 Mar; 106(3):455-62. PubMed ID: 17367069
[TBL] [Abstract][Full Text] [Related]
20. Comparative morphological and immunohistochemical study of human meningioma after intracranial transplantation into nude mice.
Friedrich S; Schwabe K; Klein R; Krusche CA; Krauss JK; Nakamura M
J Neurosci Methods; 2012 Mar; 205(1):1-9. PubMed ID: 22209769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
